The European Specialty Enzymes Market size is estimated to grow at a prominent CAGR between 2021 to 2026.
Specialty enzymes are commonly used to manufacture drugs to treat deadly diseases such as cardiovascular diseases, cancer, age-related pain, asthma, hay fever, and lysosomal storage disorders in the pharmaceutical sector. Therefore, the increasing prevalence of chronic disorders and the rising geriatric population are expected to accelerate the specialty enzymes market in emerging European countries like the United Kingdom, Italy, and France. The regional market growth is driven by specific yield optimization and catalytic reaction properties of specialty enzymes.
The specialized enzymes market in the European region is predicted to accelerate due to the multifunctional advantages of specialty enzymes in a variety of applications and technical advancements that decrease the need for chemical catalysts. Also, the usage of specialty enzymes has expanded as technologies to enhance pharmaceutical manufacture have improved, and people's concerns about quality have grown.
Owing to its growing uses, particularly in the processing of light chemicals and pure pharmaceutical drugs, pharmaceutical firms across the region have included these specialist enzymes. In addition, in recent years, there has been a shift in the tendency toward using customized enzymes to reduce dependency on traditional enzymes. As a result, these enzymes will likely penetrate the total specialized enzymes market throughout the projected period.
The growing demand for non-harmful biological catalysts in pharmaceuticals and diagnostics is influencing the market growth. On the other hand, waste reduction and energy saving are the two factors majorly driving the European specialty enzymes market growth. Moreover, the increasing rate of industrialization in emerging regions and the adoption of innovative technologies in the pharmaceutical industry are likely to provide lucrative opportunities for the market participants.
However, legal and ethical issues and a lack of consumer understanding of the benefits of specialty enzymes are expected to impede market growth, particularly in emerging markets. Also, the difficulty in keeping the pH and operational temperature of specialty enzymes is expected to restrain the market growth.
This research report on the European specialty enzymes market has been segmented and sub-segmented into the following categories:
Geographically, the European market recorded a significant share in the global specialty enzymes market over the forecast period. It is anticipated to witness a prominent share during the forecast period. The regional market growth is attributed to well-established healthcare infrastructure, favorable reimbursement policies, and increasing disposable income in emerging countries like the UK, Italy, and France.
Germany accounted for the largest share of the European Specialty Enzymes Market in 2020, and it is expected to record a predominant share during the forecast period. Increasing population, rising healthcare expenditure, and technological advancements in the healthcare sector are propelling the market growth.
Similarly, the UK is more likely to grow significantly in the Specialty Enzymes Market during the forecast period. The market growth is driven by the increasing consumption of meat and meat products, the surge in spending on premium quality products, and consumer preference for natural ingredients used in products.
On the other hand, the emerging countries in the region, such as Italy, France, and Spain, are projected to witness a promising share in the Specialty Enzymes Market in the coming years owing to the increasing prevalence of chronic diseases, rising adoption of genetic testing for these diseases and growing focus of pharmaceutical industries on the development of polymerases and nucleases enzymes.
KEY MARKET PLAYERS:
A few of the noteworthy companies operating in the Europe Specialty Enzymes Market profiled in this report are Bbi Enzymes Ltd., Basf, Codexis Inc., Nagase & Co. Ltd., Life Technologies, Advanced Enzyme Technology Ltd. Affymetrix Inc., Advanced Enzyme Technology Ltd., Amano Enzyme Inc., Roche Holding Ag., and Sanofi S.A.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.5 Y-o-Y Growth Analysis, By Source
5.1.6 Market Attractiveness Analysis, By Source
5.1.7 Market Share Analysis, By Source
188.8.131.52 Other Carbohydrases
5.2.4 Polymerases &Nucleases
5.2.7 Specialty Enzymes Used in Pharmaceuticals
5.2.8 Specialty Enzyme Used in Diagnostics
5.2.9 Specialty Enzyme Used For Research & Biotechnology
5.2.10 Y-o-Y Growth Analysis, By Type
5.2.11 Market Attractiveness Analysis, By Type
5.2.12 Market Share Analysis, By Type
184.108.40.206 Enzyme Replacement Therapy
220.127.116.11 Thrombolytic Enzymes
18.104.22.168 Digestive Enzymes
5.3.3 Research & Biotechnology
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Source
188.8.131.52 By Type
184.108.40.206 By Application
6.1.4 Market Attractiveness Analysis
220.127.116.11 By Geographical Area
18.104.22.168 By Source
22.214.171.124 By Type
126.96.36.199 By Application
6.1.5 Market Share Analysis
188.8.131.52 By Geographical Area
184.108.40.206 By Source
220.127.116.11 By Type
18.104.22.168 By Application
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Affymetrix Inc.
8.1.2 Source Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 BBI Enzymes Ltd.
8.3 Nagase & Co. Ltd.
8.4 Life Technologies
8.5 Advanced Enzyme Technology Ltd.
8.6 Roche Holding Ag
8.7 Sanofi S.A.
8.8 Codexis Inc.
8.9 Amano Enzyme Inc.
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures